Overview

Effects of Buprenorphine/Naloxone Dose on Experimental Stress Reactivity and Opioid Abstinence

Status:
Completed
Trial end date:
2020-08-01
Target enrollment:
Participant gender:
Summary
This research deals with behaviors that are part of opioid dependence. The purpose is to study how stress and medication dose can affect opioid drug use.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Wayne State University
Treatments:
Buprenorphine
Buprenorphine, Naloxone Drug Combination
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate
Morphine
Naloxone
Yohimbine